Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
111,825,275
-
Shares change
-
+10,966,691
-
Total reported value, excl. options
-
$3,615,108,333
-
Value change
-
+$350,007,462
-
Put/Call ratio
-
366%
-
Number of buys
-
126
-
Number of sells
-
104
-
Price
-
$32.45
Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q1 2023
As of 31 Mar 2023 Evolent Health, Inc. - Class A Common Stock (EVH) had 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 111,825,275 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Rock Springs Capital Management LP, Granahan Investment Management, LLC, Invesco Ltd., ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, and DIMENSIONAL FUND ADVISORS LP.
This table shows 237 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.